Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.
- Scott A Jeffers, Sonia M Tusell, +11 authors K. Holmes
- Biology, Medicine
- Proceedings of the National Academy of Sciences…
- 2 November 2004
Angiotensin-converting enzyme 2 (ACE2) is a receptor for SARS-CoV, the novel coronavirus that causes severe acute respiratory syndrome [Li, W. Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K.,… Expand
Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile-Induced Mortality in Hamsters
- G. Babcock, T. J. Broering, +9 authors W. Thomas
- Biology, Medicine
- Infection and Immunity
- 11 September 2006
ABSTRACT Clostridium difficile is the leading cause of nosocomial antibiotic-associated diarrhea, and recent outbreaks of strains with increased virulence underscore the importance of identifying… Expand
Treatment with monoclonal antibodies against Clostridium difficile toxins.
- I. Lowy, D. Molrine, +9 authors D. Ambrosino
- Medicine
- The New England journal of medicine
- 28 January 2010
BACKGROUND
New therapies are needed to manage the increasing incidence, severity, and high rate of recurrence of Clostridium difficile infection.
METHODS
We performed a randomized, double-blind,… Expand
Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor
- G. Babcock, Diana J Esshaki, W. Thomas, D. Ambrosino
- Biology, Medicine
- Journal of Virology
- 1 May 2004
ABSTRACT A novel coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV), has recently been identified as the causative agent of severe acute respiratory syndrome (SARS). SARS-CoV… Expand
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
- T. J. Broering, K. Garrity, +7 authors G. Babcock
- Biology, Medicine
- Journal of Virology
- 16 September 2009
ABSTRACT Nearly all livers transplanted into hepatitis C virus (HCV)-positive patients become infected with HCV, and 10 to 25% of reinfected livers develop cirrhosis within 5 years. Neutralizing… Expand
Development and Characterization of a Severe Acute Respiratory Syndrome—Associated Coronavirus—Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice
- T. Greenough, G. Babcock, +13 authors D. Ambrosino
- Biology, Medicine
- The Journal of infectious diseases
- 15 February 2005
Abstract Background. Severe acute respiratory syndrome (SARS) remains a significant public health concern after the epidemic in 2003. Human monoclonal antibodies (MAbs) that neutralize… Expand
Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees
- Trevor J. Morin, T. J. Broering, +15 authors G. Babcock
- Biology, Medicine
- PLoS pathogens
- 1 August 2012
Hepatitis C virus (HCV) infection is a leading cause of liver transplantation and there is an urgent need to develop therapies to reduce rates of HCV infection of transplanted livers. Approved… Expand
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
- B. Leav, B. Blair, +9 authors D. Molrine
- Medicine
- Vaccine
- 22 January 2010
BACKGROUND
Previous studies have demonstrated a correlation between Clostridium difficile anti-toxin A serum antibodies and protection against symptomatic disease and recurrence.
METHODS
A… Expand
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
- D. Ambrosino, G. Schiffman, +5 authors G. Siber
- Medicine, Biology
- The Journal of clinical investigation
- 1 June 1985
To determine whether genetic factors influence the human antibody response to polysaccharides, we correlated Ig allotypes with the concentrations of antibody to 14 bacterial capsular antigens in 130… Expand
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein.
- R. Malley, J. Devincenzo, +10 authors D. Ambrosino
- Medicine
- The Journal of infectious diseases
- 1 December 1998
Thirty-five children <2 years of age mechanically ventilated for respiratory syncytial virus (RSV) infection were randomized to receive an intravenous infusion of 15 mg/kg MEDI-493 or placebo. RSV… Expand